Joshua M Fine insider trades: Cyclo Therapeutics (CYTH) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joshua reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 29, 2021 | CYTH | ↑ Buy | 50 | $7.40 | $370 | Direct | Mar 30, 2021 (1d) |
| Nov 25, 2020 | CTDH | ↑ Buy | 25,000 | $0.08 | $2K | Direct | Nov 25, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Joshua M Fine's insider trades
Joshua M Fine is Chief Financial Officer at Cyclo Therapeutics (CYTH). Since Nov 25, 2020, Joshua has reported 2 open-market purchases worth $2K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.